Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways

References

• Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci 2012; 125(Pt 23):5591-6; PMID:23420197; http://dx.doi.org/10.1242/jcs.116392
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510(7503):92-101; PMID:24899309; http://dx.doi.org/10.1038/nature13479
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8(5):349-61; PMID:18437155; http://dx.doi.org/10.1038/nri2294
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol 2015; 27(3):200-15; PMID:25857211; http://dx.doi.org/10.1016/j.smim.2015.03.004
   PubMed Web of Science ®Google Scholar
• Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009; 61(2):119-61; PMID:19498085; http://dx.doi.org/10.1124/pr.109.001578
   PubMed Web of Science ®Google Scholar
• Dufton N, Perretti M. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacol Ther 2010; 127(2):175-88; PMID:20546777; http://dx.doi.org/10.1016/j.pharmthera.2010.04.010
   PubMed Web of Science ®Google Scholar
• Prevete N, Liotti F, Visciano C, Marone G, Melillo RM, de Paulis A. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. Oncogene 2015; 34(29):3826-38; PMID:25263443; http://dx.doi.org/10.1038/onc.2014.309
   PubMed Web of Science ®Google Scholar
• Cash JL, Norling LV, Perretti M. Resolution of inflammation: targeting GPCRs that interact with lipids and peptides. Drug Discov Today 2014; 19(8):1186-92; PMID:24993159; http://dx.doi.org/10.1016/j.drudis.2014.06.023
   PubMed Web of Science ®Google Scholar
• Gobbetti T, Ducheix S, le Faouder P, Perez T, Riols F, Boue J, Bertrand-Michel J, Dubourdeau M, Guillou H, Perretti M et al. Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor. Br J Pharmacol 2015; 172(3):910-23; PMID:25296998; http://dx.doi.org/10.1111/bph.12957
   PubMed Web of Science ®Google Scholar
• Ivanov I, Kuhn H, Heydeck D. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). Gene 2015; 573(1):1-32; PMID:26216303; http://dx.doi.org/10.1016/j.gene.2015.07.073
   PubMed Web of Science ®Google Scholar
• Brash AR, Boeglin WE, Chang MS. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci U S A 1997; 94(12):6148-52; PMID:9177185; http://dx.doi.org/10.1073/pnas.94.12.6148
   PubMed Web of Science ®Google Scholar
• Prevete N, Liotti F, Marone G, Melillo RM, de Paulis A. Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth. Pharmacol Res 2015; 102:184-91; PMID:26466865; http://dx.doi.org/10.1016/j.phrs.2015.09.017
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6(269):pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2(5):401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513(7517):202-9; PMID:25079317; http://dx.doi.org/10.1038/nature13480
   PubMed Web of Science ®Google Scholar
• Lu JM, Nurko J, Weakley SM, Jiang J, Kougias P, Lin PH, Yao Q, Chen C. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit 2010; 16(5):RA93-100; PMID:20424564
   PubMed Web of Science ®Google Scholar
• Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res 2010; 70(6):2445-54; PMID:20215512; http://dx.doi.org/10.1158/0008-5472.CAN-09-2468
   PubMed Web of Science ®Google Scholar
• Uehara Y, Mochizuki M, Matsuno K, Haino T, Asai A. Novel high-throughput screening system for identifying STAT3-SH2 antagonists. Biochem Biophys Res Commun 2009; 380(3):627-31; PMID:19285012; http://dx.doi.org/10.1016/j.bbrc.2009.01.137
   PubMed Web of Science ®Google Scholar
• Finstad HS, Drevon CA, Kulseth MA, Synstad AV, Knudsen E, Kolset SO. Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. Biochem J 1998; 336 (Pt 2):451-9; PMID:9820824; http://dx.doi.org/10.1042/bj3360451
   PubMed Web of Science ®Google Scholar
• Sun SN, Jia WD, Chen H, Ma JL, Ge YS, Yu JH, Li JS. Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells. Int J Clin Exp Pathol 2013; 6(2):281-9; PMID:23330014
   PubMed Web of Science ®Google Scholar
• Peng Y, Zheng Y, Zhang Y, Zhao J, Chang F, Lu T, Zhang R, Li Q, Hu X, Li N. Different effects of omega-3 fatty acids on the cell cycle in C2C12 myoblast proliferation. Mol Cell Biochem 2012; 367(1-2):165-73; PMID:22610825; http://dx.doi.org/10.1007/s11010-012-1329-4
   PubMed Web of Science ®Google Scholar
• Ducheix S, Montagner A, Polizzi A, Lasserre F, Marmugi A, Bertrand-Michel J, Podechard N, Al Saati T, Chetiveaux M, Baron S et al. Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor. J Hepatol 2013; 58(5):984-92; PMID:23333450; http://dx.doi.org/10.1016/j.jhep.2013.01.006
   PubMed Web of Science ®Google Scholar
• Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, Anderson RL, Stewart AG. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J 2011; 25(2):483-96; PMID:20930115; http://dx.doi.org/10.1096/fj.09-154096
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu Y, Yao X, Ping Y, Jiang T, Liu Q, Xu S, Huang J, Mou H, Gong W et al. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol 2011; 179(3):1504-12; PMID:21782780; http://dx.doi.org/10.1016/j.ajpath.2011.05.059
   PubMed Web of Science ®Google Scholar
• Belvedere R, Bizzarro V, Popolo A, Dal Piaz F, Vasaturo M, Picardi P, Parente L, Petrella A. Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells. BMC Cancer 2014; 14:961; PMID:25510623; http://dx.doi.org/10.1186/1471-2407-14-961
   PubMed Web of Science ®Google Scholar
• Snapkov I, Oqvist CO, Figenschau Y, Kogner P, Johnsen JI, Sveinbjornsson B. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis. BMC Cancer 2016; 16:490; PMID:27432059; http://dx.doi.org/10.1186/s12885-016-2545-1
   PubMed Web of Science ®Google Scholar
• Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL et al. Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest 2013; 123(4):1694-704; PMID:23454745; http://dx.doi.org/10.1172/JCI65569
   PubMed Web of Science ®Google Scholar
• Giebeler A, Streetz KL, Soehnlein O, Neumann U, Wang JM, Brandenburg LO. Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation. PloS One 2014; 9(6):e100522; PMID:24956481; http://dx.doi.org/10.1371/journal.pone.0100522
   PubMedGoogle Scholar
• Baracco EE, Pietrocola F, Buque A, Bloy N, Senovilla L, Zitvogel L, Vacchelli E, Kroemer G. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology 2016; 5(6):e1139275; PMID:27471610; http://dx.doi.org/10.1080/2162402X.2016.1139275
   PubMedGoogle Scholar
• Vacchelli E, Ma Y, Baracco EE, Zitvogel L, Kroemer G. Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: formyl peptide receptor-1. Oncoimmunology 2016; 5(5):e1118600; PMID:27467929; http://dx.doi.org/10.1080/2162402X.2015.1118600
   PubMedGoogle Scholar
• Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Hua KT, Kuo ML. Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer. Anticancer Res 2014; 34(5):2223-9; PMID:24778024
   PubMed Web of Science ®Google Scholar
• Otani T, Ikeda S, Lwin H, Arai T, Muramatsu M, Sawabe M. Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases. Biochem Biophys Res Commun 2011; 405(3):356-61; PMID:21216225; http://dx.doi.org/10.1016/j.bbrc.2010.12.136
   PubMed Web of Science ®Google Scholar
• Seifert R, Wenzel-Seifert K. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis. J Biol Chem 2001; 276(45):42043-9; PMID:11559706; http://dx.doi.org/10.1074/jbc.M106621200
   PubMed Web of Science ®Google Scholar
• Maney P, Emecen P, Mills JS, Walters JD. Neutrophil formylpeptide receptor single nucleotide polymorphism 348T>C in aggressive periodontitis. J Periodontol 2009; 80(3):492-8; PMID:19254133; http://dx.doi.org/10.1902/jop.2009.080225
   PubMed Web of Science ®Google Scholar
• Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000; 39(16):4761-8; PMID:10769133; http://dx.doi.org/10.1021/bi992551b
   PubMed Web of Science ®Google Scholar
• Van Dyke TE, Hasturk H, Kantarci A, Freire MO, Nguyen D, Dalli J, Serhan CN. Proresolving nanomedicines activate bone regeneration in periodontitis. J Dent Res 2015; 94(1):148-56; PMID:25389003; http://dx.doi.org/10.1177/0022034514557331
   PubMed Web of Science ®Google Scholar
• Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007; 179(10):7021-9; PMID:17982093; http://dx.doi.org/10.4049/jimmunol.179.10.7021
   PubMed Web of Science ®Google Scholar
• Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 2006; 20(2):401-3; PMID:16373400; http://dx.doi.org/10.1096/fj.05-4724fje
   PubMed Web of Science ®Google Scholar
• Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 2009; 50(10):4743-52; PMID:19407006; http://dx.doi.org/10.1167/iovs.08-2462
   PubMed Web of Science ®Google Scholar
• Klil-Drori AJ, Ariel A. 15-Lipoxygenases in cancer: a double-edged sword? Prostaglandins Other Lipid Mediat 2013; 106:16-22; PMID:23933488; http://dx.doi.org/10.1016/j.prostaglandins.2013.07.006
   PubMed Web of Science ®Google Scholar
• Dunbar BS, Bosire RV, Deckelbaum RJ. Omega 3 and omega 6 fatty acids in human and animal health: an African perspective. Mol Cell Endocrinol 2014; 398(1-2):69-77; PMID:25458696; http://dx.doi.org/10.1016/j.mce.2014.10.009
   PubMed Web of Science ®Google Scholar
• Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 2012; 107(Suppl 2):S228-39; PMID:22591896; http://dx.doi.org/10.1017/S0007114512001614
   PubMed Web of Science ®Google Scholar
• Song M, Nishihara R, Cao Y, Chun E, Qian ZR, Mima K, Inamura K, Masugi Y, Nowak JA, Nosho K et al. Marine omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T Cells. JAMA Oncol 2016; 2(9):1197-206; PMID:27148825; http://dx.doi.org/10.1001/jamaoncol.2016.0605
   PubMed Web of Science ®Google Scholar
• Black HS, Rhodes LE. Potential benefits of omega-3 fatty acids in non-melanoma skin cancer. J Clin Med 2016; 5(2):pii: E23; PMID:26861407; http://dx.doi.org/10.3390/jcm5020023
   PubMedGoogle Scholar
• Eltweri AM, Thomas AL, Metcalfe M, Calder PC, Dennison AR, Bowrey DJ. Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer. Clin Nutr 2017; 36(1):65-78; PMID:26833289; http://dx.doi.org/10.1016/j.clnu.2016.01.007
   PubMed Web of Science ®Google Scholar
• Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ, Connor KM, Aderman CM, Liclican E et al. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of omega-3 polyunsaturated fatty acids. Sci Transl Med 2011; 3(69):69ra12; PMID:21307302; http://dx.doi.org/10.1126/scitranslmed.3001571
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140(6):805-20; PMID:20303872; http://dx.doi.org/10.1016/j.cell.2010.01.022
   PubMed Web of Science ®Google Scholar
• Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci 2014; 15(6):9594-627; PMID:24886810; http://dx.doi.org/10.3390/ijms15069594
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009; 9(1):57-63; PMID:19052556; http://dx.doi.org/10.1038/nrc2541
   PubMed Web of Science ®Google Scholar
• Fichtner-Feigl S, Kesselring R, Strober W. Chronic inflammation and the development of malignancy in the GI tract. Trends Immunol 2015; 36(8):451-9; PMID:26194796; http://dx.doi.org/10.1016/j.it.2015.06.007
   PubMed Web of Science ®Google Scholar
• Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, Capaldo CT, Peatman E, Severson EA, Flower RJ, Perretti M et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 2008; 181(7):5035-44; PMID:18802107; http://dx.doi.org/10.4049/jimmunol.181.7.5035
   PubMed Web of Science ®Google Scholar
• Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, Hilgarth RS, Kundu K, Murthy N, Kusters D et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 2013; 123(1):443-54; PMID:23241962; http://dx.doi.org/10.1172/JCI65831
   PubMed Web of Science ®Google Scholar
• Alam A, Leoni G, Quiros M, Wu H, Desai C, Nishio H, Jones RM, Nusrat A, Neish AS. The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. Nat Microbiol 2016; 1:15021; PMID:27571978; http://dx.doi.org/10.1038/nmicrobiol.2015.21
   PubMed Web of Science ®Google Scholar